Table 1.

Study groups and survival rates.

Groups	Recipient Genotype	noperated/n survivors	% survival
Wildtype sham (saline)	Wildtype	10/8	80%
TSP2-KO sham (saline)	TSP2-KO	10/8	80%
Wildtype (WT cardios)	Wildtype	32/26	81%
TSP2-KO (TSP2-KO cardios)	TSP2-KO	35/29	83%
Wildtype sham (no injection for baseline)	Wildtype	5/5	100%
TSP2-KO sham (no injection for baseline)	TSP2-KO	5/4	80%
Wildtype (WT cardios for PCR)	Wildtype	8/6	75%
TSP2-KO (TSP2-KO for PCR)	TSP2-KO	10/6	60%
Total Wildtype mice		55/45	82%
Total TSP-KO mice		60/47	78%